ES8800254A1 - Procedimiento para la obtencion de nuevos derivados de la pristinamicina iib. - Google Patents

Procedimiento para la obtencion de nuevos derivados de la pristinamicina iib.

Info

Publication number
ES8800254A1
ES8800254A1 ES557521A ES557521A ES8800254A1 ES 8800254 A1 ES8800254 A1 ES 8800254A1 ES 557521 A ES557521 A ES 557521A ES 557521 A ES557521 A ES 557521A ES 8800254 A1 ES8800254 A1 ES 8800254A1
Authority
ES
Spain
Prior art keywords
alkyl
preparation
nitrogen
optionally substituted
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557521A
Other languages
English (en)
Other versions
ES557521A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Sante SA
Original Assignee
Rhone Poulenc Sante SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante SA filed Critical Rhone Poulenc Sante SA
Publication of ES8800254A1 publication Critical patent/ES8800254A1/es
Publication of ES557521A0 publication Critical patent/ES557521A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06182—Dipeptides with the first amino acid being heterocyclic and Pristinamycin II; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fats And Perfumes (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE LA PRISTINAMICINA IIB, DE FORMULA (I), Y DE SUS SALES DE ADICION DE ACIDO. COMPRENDE LA REACCION DE OXIDACION DE UN DERIVADO DE PRISTINAMICINA IIB, UNA DE SUS SALES O UNO DE SUS DERIVADOS PROTEGIDOS, DE FORMULA (II), EN LA QUE N VALE 0 O 1, POR TRATAMIENTO CON AGUA OXIGENADA O UN PERACIDO, A UNA TEMPERATURA COMPRENDIDA ENTRE -40GC Y 50GC, PARA OBTENER UN COMPUESTO DE FORMULA (I), EN LA QUE R PUEDE SER UNO DE VARIOS RADICALES Y N VALE 2. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SU ACTIVIDAD SOBRE STAPHYLOCOCCUS AUREUS SMITH. *FORMULA*
ES557521A 1985-01-11 1987-04-30 Procedimiento para la obtencion de nuevos derivados de la pristinamicina iib. Expired ES8800254A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8500377A FR2576022B1 (fr) 1985-01-11 1985-01-11 Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
ES8800254A1 true ES8800254A1 (es) 1987-10-16
ES557521A0 ES557521A0 (es) 1987-10-16

Family

ID=9315194

Family Applications (2)

Application Number Title Priority Date Filing Date
ES550801A Expired ES8707970A1 (es) 1985-01-11 1986-01-10 Procedimiento para la obtencion de nuevos derivados de la pristinamicina ii b
ES557521A Expired ES8800254A1 (es) 1985-01-11 1987-04-30 Procedimiento para la obtencion de nuevos derivados de la pristinamicina iib.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES550801A Expired ES8707970A1 (es) 1985-01-11 1986-01-10 Procedimiento para la obtencion de nuevos derivados de la pristinamicina ii b

Country Status (21)

Country Link
US (1) US4668669A (es)
EP (1) EP0191662B1 (es)
JP (1) JPH0662633B2 (es)
KR (1) KR930003494B1 (es)
AT (1) ATE34753T1 (es)
AU (1) AU577654B2 (es)
BR (1) BR1101136A (es)
CA (1) CA1315474C (es)
DE (1) DE3660258D1 (es)
DK (1) DK166151C (es)
ES (2) ES8707970A1 (es)
FI (1) FI83326C (es)
FR (1) FR2576022B1 (es)
GR (1) GR860054B (es)
IE (1) IE58618B1 (es)
IL (2) IL77551A (es)
LV (1) LV5269A3 (es)
MX (1) MX9203597A (es)
PT (1) PT81794B (es)
SU (1) SU1540655A3 (es)
ZA (1) ZA86152B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2599036B1 (fr) * 1986-05-22 1988-09-09 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
GB8616768D0 (en) * 1986-07-09 1986-08-13 May & Baker Ltd Process
WO1988002370A1 (en) * 1986-09-30 1988-04-07 Ciba-Geigy Ag 2-substituted-e-fused-[1,2,4]triazolo[1,5-c]pyrimidines pharmaceutical compositions and uses thereof
US4762923A (en) * 1986-11-21 1988-08-09 Merck & Co. Inc. Fermentation analogs of virginiamycin M1
DE3778359D1 (de) * 1987-07-07 1992-05-21 Rhone Poulenc Sante Verfahren zur herstellung von derivaten von pristinamycin iib.
GB8728820D0 (en) * 1987-12-09 1988-01-27 Fisons Plc Compounds
US4948791A (en) * 1989-04-10 1990-08-14 The Board Of Trustees Of The University Of Illinois Novel Cytotoxic cyclic depsipeptides from the tunicate trididemnum solidum
FR2664598A1 (fr) * 1990-07-16 1992-01-17 Rhone Poulenc Rorer Sa Procede de preparation de sulfinyl pristinamycine iib.
FR2664597B1 (fr) * 1990-07-16 1994-09-02 Rhone Poulenc Sante Procede de preparation de sulfonylpristinamycine iib.
FR2664600B1 (fr) * 1990-07-16 1994-09-02 Rhone Poulenc Sante Nouveau sel derive de la dialcoylaminoalcoyl-sulfonyl-26 pristinamycine iib.
IL121821A (en) * 1993-02-17 2000-02-17 Rhone Poulenc Rorer Sa Process for purifying a group A minority component of streptogramin some such purified components and their uses
FR2723373B1 (fr) 1994-08-02 1996-09-13 Rhone Poulenc Rorer Sa Forme purifiee de streptogramines, sa preparation et les compositions pharmaceutiques qui la contiennent
FR2755857B1 (fr) * 1996-11-19 1998-12-24 Rhone Poulenc Rorer Sa Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
FR2766489B1 (fr) 1997-07-28 1999-08-27 Rhone Poulenc Rorer Sa Derives de streptogramines, leur preparation et les compositions qui les contiennent
FR2795733B1 (fr) * 1999-06-30 2001-09-07 Aventis Pharma Sa Derives de streptogramines, leur preparation et les compositions qui les contiennent
FR2796949B1 (fr) * 1999-07-27 2001-09-21 Aventis Pharma Sa Derives de streptogramines, leur preparation et les compositions qui les contiennent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549065B1 (fr) * 1983-07-13 1985-10-25 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
FR2576022A1 (fr) 1986-07-18
KR860005831A (ko) 1986-08-13
PT81794B (pt) 1988-05-27
DK166151C (da) 1993-08-09
FI83326C (fi) 1991-06-25
ES8707970A1 (es) 1987-09-01
DE3660258D1 (en) 1988-07-07
DK166151B (da) 1993-03-15
DK11286A (da) 1986-07-12
ES550801A0 (es) 1987-09-01
JPS61165389A (ja) 1986-07-26
AU577654B2 (en) 1988-09-29
KR930003494B1 (ko) 1993-05-01
EP0191662B1 (fr) 1988-06-01
IE860051L (en) 1986-07-11
ZA86152B (en) 1986-10-29
MX9203597A (es) 1992-09-01
FR2576022B1 (fr) 1987-09-11
FI83326B (fi) 1991-03-15
IE58618B1 (en) 1993-10-20
CA1315474C (fr) 1993-03-30
BR1101136A (pt) 1999-12-07
EP0191662A1 (fr) 1986-08-20
SU1540655A3 (ru) 1990-01-30
FI860117A (fi) 1986-07-12
ATE34753T1 (de) 1988-06-15
IL83112A (en) 1991-08-16
LV5269A3 (lv) 1993-10-10
US4668669A (en) 1987-05-26
ES557521A0 (es) 1987-10-16
JPH0662633B2 (ja) 1994-08-17
GR860054B (en) 1986-03-28
PT81794A (fr) 1986-02-01
FI860117A0 (fi) 1986-01-10
DK11286D0 (da) 1986-01-10
AU5214286A (en) 1986-07-17
IL77551A (en) 1991-04-15

Similar Documents

Publication Publication Date Title
ES8800254A1 (es) Procedimiento para la obtencion de nuevos derivados de la pristinamicina iib.
ES8405787A1 (es) Un procedimiento para la preparacion de nuevos derivados de 4-amino-6,7-dimetoxi-2-piperazinoquinazolina.
GB8711802D0 (en) Dithioacetal compounds
CS9003037A2 (en) Means for chemotherapy
ES2000346A6 (es) Un procedimiento para la preparacion de derivados de distamicina
IL98681A (en) Pharmaceutical compositions comprising hydroxamate derivatives for iron removal from mammalian cells and from pathogenic organisms and some novel hydroxamate derivatives
MY108849A (en) Novel compound
DE3462333D1 (en) Synergistin derivatives, their preparation and pharmaceutical compositions thereof
DE3864336D1 (en) Aromatische thioaether.
ES2010225A6 (es) Procedimiento de preparacion de nuevos derivados de piperazina diona-2,6.
ZA905407B (en) Pyrrolo(2,1-b)thiozle derivatives
ES2001766A6 (es) Procedimiento para la preparacion de sales internas de oxidos del hidroxido de hidroxiheterociclil-alcoxifosfiniloxi-trialquilaminio,y su utilazacion como farmacos.
PH23966A (en) Imidazoquinozoline compounds as agent for treatment of nephritis
MY103577A (en) New aminoacylates of glycerol acetal
ES485333A1 (es) Procedimiento para preparar derivados 5,6,7,8-tetrahidro-4 (3h)-quinazolinonicos y sus sales

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050726